pain-management-2016_scientifictracks-abstracts

13 / 18

Notes:
Page 41
Pain Management 2016
October 03-04, 2016
Volume 5, Issue 5(Suppl) J Pain Relief
ISSN: 2167-0846 JPAR, an open access journal
conferenceseries .com
October 03-04, 2016 Vancouver, Canada
International Conference on
Pain Research & Management
Ali El Deeb, J Pain Relief 2016, 5:5(Suppl)
Evaluation of using botulinum toxin (A) in the treatment of myofascial pain syndrome
Ali El Deeb
Tanta University, Egypt
Myofascial pain syndrome (MPS) is a disorder which has become a topic over the past two decades and now. 10 patients
(9 female and 1 male) complaining of unilateral MPS were injected with botulinum toxin type A (BTX-A) in masseter
and temporalis muscles extra orally under electromyographic guidance (EMG), since they are the primary muscles responsible
for pain in ear region and temporal headache, respectively, which cause limitation of mandibular movement and development
of MPS. EMG evaluations of the results together with clinical one were taken at baseline before injection, after 1, 2, 3 and 6
months following the last injection. The study revealed that BTX-A reduced the severity of symptoms and improve functional
abilities for patients with MPS and these extend beyond its muscle relaxing effects.
Biography
Ali El Deeb has completed his MD from Tanta University and Post-doctoral studies from Tanta University, Faculty of Medicine. He is the Supervisor of Physical
Medicine, Rheumatology and Rehabilitation in new Tanta University Hospital. He is also a Reviewer for Tanta Medical Journal. He has published many papers in
the reputed.